{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:08:17Z","timestamp":1790194097834,"version":"4.1.0"},"reference-count":18,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2002,12,12]],"date-time":"2002-12-12T00:00:00Z","timestamp":1039651200000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Mass Spectrom."],"published-print":{"date-parts":[[2002,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Purines and pyrimidines are of interest owing to their significance in processes in living organisms. Mass spectrometry is a promising analytical tool utilized in their analysis. Two atmospheric pressure ionization (API) methods (electrospray ionization (ESI) and atmospheric pressure chemical ionization (APCI)) in both negative and positive modes applied to selected purine and pyrimidine metabolites (markers of inherited metabolic disorders) were studied. APCI is less sensitive to alkali metal cations present in a sample and offers higher response than ESI for studied compounds. Both of the techniques afford quasi\u2010molecular ions, but fragmentation also occurs to a certain extent. However, the application of collision\u2010induced dissociation of quasi\u2010molecular ions is essential to confirm a certain metabolite in a sample. Fragmentation of both positive and negative ions was evaluated using multi\u2010stage mass spectrometric experiments. Typical neutral losses correspond to molecules NH<jats:sub>3<\/jats:sub>, H<jats:sub>2<\/jats:sub>O, HCN, CO, H<jats:sub>2<\/jats:sub>NCN, HNCO and CO<jats:sub>2<\/jats:sub>. The ion [NCO]<jats:sup>\u2212<\/jats:sup> arises in the negative mode. The cleavage of the glycosidic C\u2014N bond is characteristic for relevant metabolites. Other neutral losses (CH<jats:sub>2<\/jats:sub>O, C<jats:sub>2<\/jats:sub>H<jats:sub>4<\/jats:sub>O<jats:sub>2<\/jats:sub> and C<jats:sub>3<\/jats:sub>H<jats:sub>6<\/jats:sub>O<jats:sub>3<\/jats:sub>) originate from fragmentation of the glycosidic part of the molecules. In addition to fragmentation, the formation of adducts of some ions with applied solvents (H<jats:sub>2<\/jats:sub>O, CH<jats:sub>3<\/jats:sub>OH) was observed. The composition of the solution infused into the ion source affects the appearance of the mass spectra. Tandem mass spectra allow one to distinguish compounds with the same molecular mass (uridine\u2013pseudouridine and adenosine\u20132'\u2010deoxyguanosine). Flow injection analysis APCI\u2010MS\/MS was tested on model samples of human urines corresponding to adenosine deaminase deficiency and xanthine oxidase deficiency. In both cases, the results showed potential diagnostic usefulness. Copyright \u00a9 2002 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/jms.389","type":"journal-article","created":{"date-parts":[[2002,12,18]],"date-time":"2002-12-18T09:04:44Z","timestamp":1040202284000},"page":"1242-1248","source":"Crossref","is-referenced-by-count":40,"title":["Atmospheric pressure ionization mass spectrometry of purine and pyrimidine markers of inherited metabolic disorders"],"prefix":"10.1002","volume":"37","author":[{"given":"Petr","family":"Fry\u010d\u00e1k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Hu\u0161kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Lemr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,12,17]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1021\/cr990077"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199509000-00009"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/clinchem\/46.2.149","article-title":"Improved stable isotope dilution\u2013gas chromatography\u2013mass spectrometry method for serum or plasma free 3\u2010hydroxy\u2010fatty acids and its utility for the study of disorders of mitochondrial fatty acid beta\u2010oxidation","volume":"46","author":"Jones PM","year":"2000","journal-title":"Clin. Chem."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/43.7.1129"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1042\/bst0240932"},{"key":"e_1_2_6_7_2","first-page":"397","volume-title":"Techniques in Diagnostic Human Biochemical Genetics: a Laboratory Manual","author":"Simmonds HA","year":"1991"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199312000-00012"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/clinchem\/45.4.539","article-title":"H\u20101\u2010NMR spectroscopy of body fluids: inborn errors of purine and pyrimidine metabolism","volume":"45","author":"Wevers RA","year":"1999","journal-title":"Clin. Chem."},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(78)90452-7"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/clinchem\/46.4.445","article-title":"Rapid screening of high\u2010risk patients for disorders of purine and pyrimidine metabolism using HPLC\u2013electrospray tandem mass spectrometry of liquid urine or urine\u2010soaked filter paper strips","volume":"46","author":"Ito T","year":"2000","journal-title":"Clin. Chem."},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005628624520"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1093\/clinchem\/45.12.2086","article-title":"Capillary electrophoresis for detection of inherited disorders of purine and pyrimidine metabolism","volume":"45","author":"Adam T","year":"1999","journal-title":"Clin. Chem."},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja00036a014"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/1044-0305(94)85049-6"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/07328319808003457"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1021\/ac9906429"},{"key":"e_1_2_6_18_2","volume-title":"Proceedings of the 49th ASMS Conference on Mass Spectrometry and Allied Topics","author":"Kamel AM","year":"2001"},{"key":"e_1_2_6_19_2","first-page":"326","article-title":"In vivo metabolism of 2,6,9\u2010trisubstituted purine\u2010derived cyclin\u2010dependent kinase inhibitor bohemine in mice: glucosidation as the principal metabolic route","volume":"29","author":"Chmela Z","year":"2001","journal-title":"Drug Metab. Dispos."}],"container-title":["Journal of Mass Spectrometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjms.389","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jms.389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T18:06:10Z","timestamp":1760637970000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/jms.389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["10.1002\/jms.389"],"URL":"https:\/\/doi.org\/10.1002\/jms.389","archive":["Portico"],"relation":{},"ISSN":["1076-5174","1096-9888"],"issn-type":[{"value":"1076-5174","type":"print"},{"value":"1096-9888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}